Bath & Body Works (NYSE:BBWI) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says

Bath & Body Works (NYSE:BBWI) had its price objective increased by equities research analysts at Deutsche Bank Aktiengesellschaft from $51.00 to $52.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential upside of 44.77% from the company’s current price.

A number of other equities analysts have also recently issued reports on the stock. Bank of America decreased their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a research report on Thursday, August 29th. Citigroup lowered their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research report on Tuesday, August 20th. Robert W. Baird cut their price objective on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. Morgan Stanley decreased their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. Finally, Evercore ISI cut their price target on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a report on Wednesday, August 28th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Bath & Body Works has an average rating of “Moderate Buy” and a consensus target price of $41.88.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $35.92 on Tuesday. Bath & Body Works has a one year low of $26.20 and a one year high of $52.99. The business’s 50 day simple moving average is $30.81 and its two-hundred day simple moving average is $35.65. The stock has a market capitalization of $7.87 billion, a P/E ratio of 8.83, a price-to-earnings-growth ratio of 1.14 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.35 by $0.02. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Sell-side analysts expect that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Gina Boswell bought 6,000 shares of the company’s stock in a transaction on Wednesday, October 9th. The shares were acquired at an average cost of $29.64 per share, with a total value of $177,840.00. Following the completion of the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 2.53 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Hedge Funds Weigh In On Bath & Body Works

Institutional investors and hedge funds have recently modified their holdings of the stock. Anomaly Capital Management LP purchased a new stake in Bath & Body Works during the 2nd quarter valued at about $113,995,000. FMR LLC lifted its stake in shares of Bath & Body Works by 17,496.5% in the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after buying an additional 2,501,828 shares in the last quarter. KBC Group NV lifted its stake in shares of Bath & Body Works by 9,023.5% in the third quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after buying an additional 1,683,160 shares in the last quarter. Erste Asset Management GmbH purchased a new stake in shares of Bath & Body Works during the third quarter valued at approximately $50,483,000. Finally, Lone Pine Capital LLC increased its position in shares of Bath & Body Works by 15.8% during the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after acquiring an additional 1,547,399 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.